Avenir Corp Cytosorbents Corp Transaction History
Avenir Corp
- $948 Million
- Q4 2024
A detailed history of Avenir Corp transactions in Cytosorbents Corp stock. As of the latest transaction made, Avenir Corp holds 3,093,946 shares of CTSO stock, worth $3.77 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
3,093,946
Previous 2,975,559
3.98%
Holding current value
$3.77 Million
Previous $4.46 Million
37.62%
% of portfolio
0.29%
Previous 0.45%
Shares
25 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Skylands Capital, LLC2.78MShares$3.39 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.38 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$2.05 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.52 Million0.18% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.2MShares$1.47 Million0.05% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $53.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...